Determinants and effects of vitamin D supplementation on serum 25-hydroxy-vitamin D levels in patients with rheumatoid arthritis

M. Varenna, M. Manara, F. P. Cantatore, A. Del Puente, O. Di Munno, N. Malavolta, G. Minisola, S. Adami, L. Sinigaglia, M. Rossini

Research output: Contribution to journalArticle

28 Citations (Scopus)

Abstract

Objective: Osteoporosis (OP) and increased risk of fracture are relevant features in patients with rheumatoid arthritis (RA). Low levels of serum vitamin D are frequently reported and correlate with a higher RA activity. This study evaluated factors related with the prescription of vitamin D supplements in RA patients and variables influencing the achievement of adequate vitamin D levels. Methods: Study population was made up by 1168 consecutive RA patients from 22 Italian rheumatology centers. Demographic and clinical variables data were collected and 250H serum vitamin D was measured in all patients. Insufficient serum 250H vitamin D levels were defined as values lower than 20 ng/mL. Results: The majority of patients (56.0%) was not taking vitamin D supplements. Among the 514 supplemented patients, 196 (38.1%) were taking insufficient dosages (≤440 IU/day). Variables related with the prescription of supplements were older age, female sex, previous bone density assessment and OP diagnosis. Among the 318 patients using daily supplements ≥800 IU, 88 patients (27.7%) did not reach adequate levels of vitamin D. In these patients a higher HAQ score (OR for 1 point=1.62, 95% CI: 1.06-2.49; p=0.03) and poor sun exposure (OR=238, 95% CI: 1.05-5.55; p=0..04) were predictors of vitamin D insufficiency. Conclusion: Vitamin D deficiency is common in patients with RA, even in patients who are regularly using supplements. Vitamin D supplementation is often ineffective even at the recommended dose of 800 IU/day in more disabled patients.

Original languageEnglish
Pages (from-to)714-719
Number of pages6
JournalClinical and Experimental Rheumatology
Volume30
Issue number5
Publication statusPublished - 2012

Fingerprint

Vitamin D
Rheumatoid Arthritis
Serum
ametantrone
Osteoporosis
Prescriptions
Vitamin D Deficiency
Rheumatology
Solar System
Bone Density
Demography

Keywords

  • Drug therapy
  • Epidemiology
  • Osteoporosis
  • Rheumatoid arthritis
  • Vitamin D

ASJC Scopus subject areas

  • Rheumatology
  • Immunology
  • Immunology and Allergy

Cite this

Varenna, M., Manara, M., Cantatore, F. P., Del Puente, A., Di Munno, O., Malavolta, N., ... Rossini, M. (2012). Determinants and effects of vitamin D supplementation on serum 25-hydroxy-vitamin D levels in patients with rheumatoid arthritis. Clinical and Experimental Rheumatology, 30(5), 714-719.

Determinants and effects of vitamin D supplementation on serum 25-hydroxy-vitamin D levels in patients with rheumatoid arthritis. / Varenna, M.; Manara, M.; Cantatore, F. P.; Del Puente, A.; Di Munno, O.; Malavolta, N.; Minisola, G.; Adami, S.; Sinigaglia, L.; Rossini, M.

In: Clinical and Experimental Rheumatology, Vol. 30, No. 5, 2012, p. 714-719.

Research output: Contribution to journalArticle

Varenna, M, Manara, M, Cantatore, FP, Del Puente, A, Di Munno, O, Malavolta, N, Minisola, G, Adami, S, Sinigaglia, L & Rossini, M 2012, 'Determinants and effects of vitamin D supplementation on serum 25-hydroxy-vitamin D levels in patients with rheumatoid arthritis', Clinical and Experimental Rheumatology, vol. 30, no. 5, pp. 714-719.
Varenna, M. ; Manara, M. ; Cantatore, F. P. ; Del Puente, A. ; Di Munno, O. ; Malavolta, N. ; Minisola, G. ; Adami, S. ; Sinigaglia, L. ; Rossini, M. / Determinants and effects of vitamin D supplementation on serum 25-hydroxy-vitamin D levels in patients with rheumatoid arthritis. In: Clinical and Experimental Rheumatology. 2012 ; Vol. 30, No. 5. pp. 714-719.
@article{597b7ee0d84a48069efea23546d50cca,
title = "Determinants and effects of vitamin D supplementation on serum 25-hydroxy-vitamin D levels in patients with rheumatoid arthritis",
abstract = "Objective: Osteoporosis (OP) and increased risk of fracture are relevant features in patients with rheumatoid arthritis (RA). Low levels of serum vitamin D are frequently reported and correlate with a higher RA activity. This study evaluated factors related with the prescription of vitamin D supplements in RA patients and variables influencing the achievement of adequate vitamin D levels. Methods: Study population was made up by 1168 consecutive RA patients from 22 Italian rheumatology centers. Demographic and clinical variables data were collected and 250H serum vitamin D was measured in all patients. Insufficient serum 250H vitamin D levels were defined as values lower than 20 ng/mL. Results: The majority of patients (56.0{\%}) was not taking vitamin D supplements. Among the 514 supplemented patients, 196 (38.1{\%}) were taking insufficient dosages (≤440 IU/day). Variables related with the prescription of supplements were older age, female sex, previous bone density assessment and OP diagnosis. Among the 318 patients using daily supplements ≥800 IU, 88 patients (27.7{\%}) did not reach adequate levels of vitamin D. In these patients a higher HAQ score (OR for 1 point=1.62, 95{\%} CI: 1.06-2.49; p=0.03) and poor sun exposure (OR=238, 95{\%} CI: 1.05-5.55; p=0..04) were predictors of vitamin D insufficiency. Conclusion: Vitamin D deficiency is common in patients with RA, even in patients who are regularly using supplements. Vitamin D supplementation is often ineffective even at the recommended dose of 800 IU/day in more disabled patients.",
keywords = "Drug therapy, Epidemiology, Osteoporosis, Rheumatoid arthritis, Vitamin D",
author = "M. Varenna and M. Manara and Cantatore, {F. P.} and {Del Puente}, A. and {Di Munno}, O. and N. Malavolta and G. Minisola and S. Adami and L. Sinigaglia and M. Rossini",
year = "2012",
language = "English",
volume = "30",
pages = "714--719",
journal = "Clinical and Experimental Rheumatology",
issn = "0392-856X",
publisher = "Clinical and Experimental Rheumatology S.A.S.",
number = "5",

}

TY - JOUR

T1 - Determinants and effects of vitamin D supplementation on serum 25-hydroxy-vitamin D levels in patients with rheumatoid arthritis

AU - Varenna, M.

AU - Manara, M.

AU - Cantatore, F. P.

AU - Del Puente, A.

AU - Di Munno, O.

AU - Malavolta, N.

AU - Minisola, G.

AU - Adami, S.

AU - Sinigaglia, L.

AU - Rossini, M.

PY - 2012

Y1 - 2012

N2 - Objective: Osteoporosis (OP) and increased risk of fracture are relevant features in patients with rheumatoid arthritis (RA). Low levels of serum vitamin D are frequently reported and correlate with a higher RA activity. This study evaluated factors related with the prescription of vitamin D supplements in RA patients and variables influencing the achievement of adequate vitamin D levels. Methods: Study population was made up by 1168 consecutive RA patients from 22 Italian rheumatology centers. Demographic and clinical variables data were collected and 250H serum vitamin D was measured in all patients. Insufficient serum 250H vitamin D levels were defined as values lower than 20 ng/mL. Results: The majority of patients (56.0%) was not taking vitamin D supplements. Among the 514 supplemented patients, 196 (38.1%) were taking insufficient dosages (≤440 IU/day). Variables related with the prescription of supplements were older age, female sex, previous bone density assessment and OP diagnosis. Among the 318 patients using daily supplements ≥800 IU, 88 patients (27.7%) did not reach adequate levels of vitamin D. In these patients a higher HAQ score (OR for 1 point=1.62, 95% CI: 1.06-2.49; p=0.03) and poor sun exposure (OR=238, 95% CI: 1.05-5.55; p=0..04) were predictors of vitamin D insufficiency. Conclusion: Vitamin D deficiency is common in patients with RA, even in patients who are regularly using supplements. Vitamin D supplementation is often ineffective even at the recommended dose of 800 IU/day in more disabled patients.

AB - Objective: Osteoporosis (OP) and increased risk of fracture are relevant features in patients with rheumatoid arthritis (RA). Low levels of serum vitamin D are frequently reported and correlate with a higher RA activity. This study evaluated factors related with the prescription of vitamin D supplements in RA patients and variables influencing the achievement of adequate vitamin D levels. Methods: Study population was made up by 1168 consecutive RA patients from 22 Italian rheumatology centers. Demographic and clinical variables data were collected and 250H serum vitamin D was measured in all patients. Insufficient serum 250H vitamin D levels were defined as values lower than 20 ng/mL. Results: The majority of patients (56.0%) was not taking vitamin D supplements. Among the 514 supplemented patients, 196 (38.1%) were taking insufficient dosages (≤440 IU/day). Variables related with the prescription of supplements were older age, female sex, previous bone density assessment and OP diagnosis. Among the 318 patients using daily supplements ≥800 IU, 88 patients (27.7%) did not reach adequate levels of vitamin D. In these patients a higher HAQ score (OR for 1 point=1.62, 95% CI: 1.06-2.49; p=0.03) and poor sun exposure (OR=238, 95% CI: 1.05-5.55; p=0..04) were predictors of vitamin D insufficiency. Conclusion: Vitamin D deficiency is common in patients with RA, even in patients who are regularly using supplements. Vitamin D supplementation is often ineffective even at the recommended dose of 800 IU/day in more disabled patients.

KW - Drug therapy

KW - Epidemiology

KW - Osteoporosis

KW - Rheumatoid arthritis

KW - Vitamin D

UR - http://www.scopus.com/inward/record.url?scp=84870266602&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84870266602&partnerID=8YFLogxK

M3 - Article

C2 - 22766134

AN - SCOPUS:84870266602

VL - 30

SP - 714

EP - 719

JO - Clinical and Experimental Rheumatology

JF - Clinical and Experimental Rheumatology

SN - 0392-856X

IS - 5

ER -